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Abstract
Background:  MicroRNAs (miRNAs) are small endogenous non-coding interfering RNA
molecules regarded as major regulators in eukaryotic gene expression. Different methods are
employed for miRNA expression profiling. For a better understanding of their role in essential
biological processes, convenient methods for differential miRNA expression analysis are required.
Results: Here, we present the miR-Q assay as a highly sensitive quantitative reverse transcription
PCR (qRT-PCR) for expression analysis of small RNAs such as miRNA molecules. It shows a high
dynamic range of 6 to 8 orders of magnitude comprising a sensitivity of up to 0.2 fM miRNA, which
corresponds to single copies per cell. There is nearly no cross reaction among closely-related
miRNA family members, which points to the high specificity of the assays. Using this approach, we
quantified the expression of let-7b in different human cell lines as well as miR-145 and miR-21
expression in porcine intestinal samples.
Conclusion: miR-Q is a cost-effective and highly specific approach, which neither requires the use
of fluorochromic probes, nor Locked Nucleic Acid (LNA)-modified oligonucleotides. Moreover, it
provides a remarkable increase in specificity and simplified detection of small RNAs.
Background
RNA interference (RNAi) is an evolutionarily-conserved
process that modulates gene expression. Recently, miRNA
molecules have been described as playing a major role
among non-coding small interfering RNAs. MiRNAs rep-
resent an abundant and highly conserved family of endog-
enous single-stranded small RNA molecules of
approximately 20–25 nucleotides in length. The high evo-
lutionary conservation of miRNAs from distantly related
species indicates their role in various crucial biological
processes. Recent studies have demonstrated that miRNAs
act as major regulators of developmental timing, cellular
differentiation, apoptosis, and signalling pathways [1]. In
plants, RNAi has also been described as a phenomenon
called post-transcriptional gene silencing [2]. Within this
context, miRNAs posses similar functions in plants such
as organ development, signal transduction, and response
to environmental stress [3].
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Animal miRNAs derive from long endogenous primary
transcripts with a local stem-loop structure, which is suc-
cessively cleaved by cellular RNases to build the mature
miRNA [4]. One of the strands interacts with the RNA-
induced silencing complex (RISC) and binds to a target
site, which is located in the 3' UTR of the related mRNA.
Most animal miRNAs bind to their targets with incom-
plete complementarity [1], while their regulatory impact
is mainly based on the reduction of translation efficiency,
rather than on enhanced mRNA degradation [5].
Due to the enormous regulative importance of miRNAs,
research on miRNA expression analysis has recently
increased. Although miRNAs represent a relatively abun-
dant class of transcripts, their expression levels vary
greatly among species and tissues [6]. Various methods
are employed for detection and differential expression
analysis of miRNAs in biological samples. Initial miRNA
expression studies were performed by means of Northern
blot analysis [7]. This method is well-established but is
very laborious and highly limited, regarding sample
throughputs. Recently, Microarrays have been used for
genome-wide miRNA profiling based on different
processing chemistries [8-10]. Microarrays provide a
robust platform for fast screening and comparative expres-
sion analysis of miRNAs, but are limited, regarding accu-
rate quantification of gene expression and need high
quantities of RNA. Thus, less abundant miRNAs often
escape detection by technologies such as cloning, North-
ern blot analysis and Microarray. A single-molecule
method for quantification of miRNA expression was
introduced by Neely et al. [11]. Although this technique
represents a modern alternative, it has a detection limit of
500 fM. Additionally, the method is utilised by a cost-
intensive device, which may be unaffordable for many
research groups.
A highly convenient and reliable method for differential
gene expression analysis is considered to be qRT-PCR
[12], which exhibits high sensitivity and target specificity.
It is 1000-fold more sensitive than methods that are based
on hybridisation [13] and can even detect a few target cop-
ies [14]. However, the small size of miRNAs requires sub-
stantial modification of this method because ordinary
PCR primers are usually the same size as the small RNA
molecules being analysed. The first miRNA real-time PCR
approach was based on detection and quantification of
miRNA precursors [15,16]. However, other studies have
shown that the cellular steady-state level of miRNA pre-
cursors does not correspond to cellular concentrations of
mature miRNAs [17,18]. Chen and colleagues [19] have
developed a quantitative stem-loop RT-PCR for detection
of mature miRNAs that is based on TaqMan assays. Their
assay displays high sensitivity and dynamic range and
allows for discrimination between members of miRNA
families such as let-7. This assay and a few others have
recently become commercialised and are rather costly.
Raymond et al. [18] have designed a SYBR Green real-time
RT-PCR for detection of mature miRNA molecules using
LNA-modified primers. Most of their developed assays are
described as being sensitive to femtomolar concentra-
tions. However, the performance and sensitivity of 70% of
the analysed assays strictly depend on the use of LNA-
modified primers, which increases the costs of this
approach.
Due to the rising general interest in miRNA expression
and their regulative impact on important biological proc-
esses, more sensitive and competitive alternatives applica-
tions are in demand. On this account, we have developed
a new cost-effective, highly sensitive, and reliable qRT-
PCR for quantification of small RNA molecules such as
miRNAs. The method called miR-Q is based on primer
extension, followed by a novel quantitative PCR (qPCR)
approach that is carried out using three DNA-oligonucle-
otides. The assay exhibits high sensitivity, linearity, and
discriminative power without the use of complex fluoro-
chromic probes or LNA-modified oligonucleotides.
Results
General assay design
The novel miR-Q approach has been introduced for detec-
tion, quantification, and differential expression profiling
of small RNA molecules, in particular miRNAs, in a com-
plex sample. During the first step, miRNA molecules are
converted into cDNA and simultaneously elongated by
reverse transcription using a miRNA-specific oligonucle-
otide with 5' overhang (RT6-miR-x, x indicates one of the
ten particular miRNAs). Subsequently, cDNA molecules
are amplified and quantified by means of a novel qPCR
approach based on utilising three DNA-oligonucleotides
at different concentrations (Figure 1). Primarily, a DNA-
oligonucleotide molecule (RT6-miR-x) is used for reverse
transcription, which comprises two main sequence por-
tions. The terminal six bases at the 3' end of RT6-miR-x are
miRNA-specific and hybridise to the template RNA mole-
cule of interest. This oligonucleotide molecule also com-
prises a second sequence portion, enabling the binding of
a universal primer (MP-fw) to prime the exponential DNA
amplification. For subsequent qPCR analysis, another oli-
gonucleotide molecule (short-miR-x-rev) is employed
comprising a miRNA-specific sequence portion at its 3'
end. Therefore, short-miR-x-rev can hybridise to the cDNA
molecule (complementary to the target miRNA) gener-
ated after the reverse transcriptase reaction. In addition,
the 5' overhang provides a terminal binding sequence for
another universal primer (MP-rev). Consequently, two 5'
overhangs are introduced to convert and elongate the
small RNA molecule. The final exponential amplification
is accomplished by means of universal primers (MP-fwBMC Molecular Biology 2008, 9:34 http://www.biomedcentral.com/1471-2199/9/34
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and MP-rev), which hybridise to terminal binding sites of
the overhangs. These universal primers are not assay-spe-
cific and are therefore employed independently of various
analysed miRNA molecules. The universal overhang
sequences of the reverse primers as well as RT primers
have been deduced from mycobacterial genome, finally
being optimised for negligible complementarities and
dimer formation. The mentioned sequence parts were
used to perform blast searches using the Wublastn option
of miRBase, Release 9.2 [20]. These universal overhang
sequences show no similarity with any known miRNA
using an Evalue cutoff = 20. Even at higher Evalue cutoffs
(< 40) only three miRNA molecules show marginal
homology to the conserved regions (ebv-miR-BART5,
rlcv-miR-rL1-8, and hsa-miR-618).
The final detection and quantification of template miRNA
molecules are performed by real-time acquisition of the
SYBR Green fluorescence, utilising a calibration curve.
Assay validation, sensitivity, and dynamic range
Initial assays were performed with miRNA-specific oligo-
nucleotides possessing an overlap of 6 bases with the RT6-
miR-x, which was used for the initial primer extension
reaction to convert and elongate the miRNA molecule in
cDNA. Although PCR reactions were performed under
stringent conditions, the application of oligonucleotides
with 6 overlapping bases produced high background from
30 cycles onwards. Hereafter, we evaluated the use of
short-miR-x-rev molecules, which featured basically no or,
at most, 3 overlapping bases. The use of shortened
miRNA-specific reverse oligonucleotides resulted in a
Schematic description of assay design Figure 1
Schematic description of assay design. The miRNA is first converted and simultaneously elongated into a cDNA molecule 
using a miRNA-specific oligonucleotide with 5' overhang (RT6-miR-x) and six complementary bases (red). Detection and ampli-
fication of the relating cDNA are employed, using a novel PCR approach with three different oligonucleotides at different con-
centrations within the same assay. The cDNA sequence (blue) is first detected and elongated by a specific oligonucleotide with 
5' overhang (short-miR-x-rev). Exponential amplification is then performed using two terminal universal primers (MP-fw &MP-rev).
5‘ 3‘ miRNA
5‘
3‘
5‘
miRNA 5‘ 3‘
3‘
5‘
3‘
5‘
3‘
5‘ 3‘
5‘ 3‘
RT6-miR-x
short-miR-x-rev
Reverse Transcription 
using miRNA specific 
hexamers with 5’-overhang
SYBR green qPCR
using a novel approach 
with 1 miRNA-specific and 
2 universal primers
MP-fw MP-revBMC Molecular Biology 2008, 9:34 http://www.biomedcentral.com/1471-2199/9/34
Page 4 of 13
(page number not for citation purposes)
higher sensitivity of all assays and a loss of background
over 40 cycles.
The dynamic range and sensitivity of all ten miR-Q assays
were first proven by performing RT reactions, using the
particular synthetic miRNA molecules spiked into 50 ng
bacterial total RNA, representing a complex RNA back-
ground. Primarily, the assay-specific Tanopt was evaluated
by performing a conventional gradient PCR (annealing
temperature gradient: 53–65°C), using an RT reaction
prepared with 10 pM synthetic miRNA, with each of the
ten containing 50 ng bacterial total RNA as a template.
The resulting specific Tanopt of every assay is indicated in
Table 1.
Certain amounts of synthetic miRNAs (10 nM – 1 fM in
RT reaction) were applied in order to analyse the dynamic
range of the approach. The linearity and sensitivity of the
approach were first evaluated using synthetic miR-145,
with bacterial total RNA present. The miR-145 assay
exhibited excellent linearity over 8 orders of magnitude,
detecting as low as 0.2 fM synthetic miR-145 (Figure 2A).
The assay exhibited high specificity and sensitivity for
miR-145, showing no background signal over 40 cycles
either in the non-spiked bacterial total RNA control or in
the no template control (Figure 2B). Furthermore, nine
distinct miRNA assays were designed and evaluated in the
same way using synthetic miRNA molecules and bacterial
total RNA as complex background. All of the ten assays
showed linearities between the log of miRNA concentra-
tion and threshold cycle (Ct) values over more than 6
orders of magnitude. All of the studied assays comprised
a high sensitivity showing a minimum detection level of
at least 20 fM synthetic miRNA, while most of the assays
offered a sensitivity of 2 fM. As indicated in Figure 3, most
of the validated assays (miR-200c, miR-16, let-7a, let-7b, 
Table 1: Oligonucleotides used in this study. The assay-specific annealing temperatures are given in the bottom right column. Differing 
bases among members of the let-7 family are indicated in red. Binding sequences for universal primers are underlined and the miRNA 
specific sequences are indicated in bold.
Synthetic miRNA molecules and DNA-
oligonucleotides for RT and qPCR
Sequence (5' to 3') Tanopt of miR-Q assays [°C]
let-7a uga ggu agu agg uug uau agu u
let-7b uga ggu agu agg uug ugu ggu u
let-7c uga ggu agu agg uug uau ggu u
miR-16 uag cag cac gua aau auu ggc g
miR-21 uag cuu auc aga cug aug uug a
miR-23b auc aca uug cca ggg auu acc
miR-27a uuc aca gug gcu aag uuc cgc
miR-141 uaa cac ugu cug gua aag aug g
miR-145 guc cag uuu ucc cag gaa ucc cuu
miR-200c uaa uac ugc cgg gua aug aug g
RT6-let-7a tgt cag gca acc gta ttc acc gtg agt ggt aac tat
RT6-let-7b tgt cag gca acc gta ttc acc gtg agt ggt aac cac
RT6-let-7c tgt cag gca acc gta ttc acc gtg agt ggt aac cat
RT6- miR-16 tgt cag gca acc gta ttc acc gtg agt ggt cgc caa
RT6- miR-21 tgt cag gca acc gta ttc acc gtg agt ggt tca aca
RT6- miR-23b tgt cag gca acc gta ttc acc gtg agt gct ggt aat
RT6- miR-27a tgt cag gca acc gta ttc acc gtg agt ggt gcg gaa
RT6- miR-141 tgt cag gca acc gta ttc acc gtg agt ggt cca tct
RT6- miR-145 tgt cag gca acc gta ttc acc gtg agt ggt aag gga
RT6- miR-200c tgt cag gca acc gta ttc acc gtg agt ggt cca tca
short-let-7a-rev cgt cag atg tcc gag tag agg ggg aac ggc gtg agg tag tag gtt gta ta 56
short-let-7b-rev cgt cag atg tcc gag tag agg ggg aac ggc gtg agg tag tag gtt gtg tg 56
short-let-7c-rev cgt cag atg tcc gag tag agg ggg aac ggc gtg agg tag tag gtt gta tg 56
short-miR-16-rev cgt cag atg tcc gag tag agg ggg aac ggc gta gca gca cgt aaa ta 59
short-miR-21-rev cgt cag atg tcc gag tag agg ggg aac ggc gta gct tat cag act ga 59
short-miR-23b-rev cgt cag atg tcc gag tag agg ggg aac ggc gat cac att gcc agg g 58
short-miR-27a-rev cgt cag atg tcc gag tag agg ggg aac ggc gtt cac agt ggc taa g 57
short-miR-141-rev cgt cag atg tcc gag tag agg ggg aac ggc gta aca ctg tct ggt aaa g 56
short-miR-145-rev cgt cag atg tcc gag tag agg ggg aac ggc ggt cca gtt ttc cca gga a 60
short-miR-200c-rev cgt cag atg tcc gag tag agg ggg aac ggc gta ata ctg ccg ggt aa 59
5S rRNA fw gcc cga tct cgt ctg atc t 60
5S rRNA rev agc cta cag cac ccg gta tt
MP-fw tgt cag gca acc gta ttc acc
MP-rev cgt cag atg tcc gag tag aggBMC Molecular Biology 2008, 9:34 http://www.biomedcentral.com/1471-2199/9/34
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Amplification plot and melting curve of the proposed miR-145 miR-Q assay Figure 2
Amplification plot and melting curve of the proposed miR-145 miR-Q assay. A) Amplification plot of synthetic miR-
145 with 50 ng bacterial total RNA present as complex background. Target input ranged between 2 nM and 0.2 fM in a miR-Q 
reaction. B) SYBR green melting curve of the miR-145 assay. Neither the non-spiked bacterial total RNA control, nor H2O 
control showed a background signal over 40 cycles.
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Dynamic range and sensitivity limit of ten miR-Q assays Figure 3
Dynamic range and sensitivity limit of ten miR-Q assays. Each value represents the mean (± SD) of three measure-
ments. They showed dynamic ranges between 6 and 8 orders of magnitude, comprising a sensitivity of up to 0.2 fM synthetic 
miRNA. A) Dynamic ranges of miR-Q assays: miR-200c (black triangles), miR-145 (black circles), and miR-27a (black rhombi). 
B) Dynamic ranges of miR-Q assays: miR-21 (red rhombi), miR-16 (red squares), miR-23b (red triangles), and miR-141 (red cir-
cles). C) Dynamic ranges of miR-Q assays: let-7a (blue triangles), let-7b (blue rhombi), and let-7c (blue circles).
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and let-7c) showed linearities over 7 orders of magnitude,
detecting as low as 2 fM synthetic miRNA. Four of the ana-
lysed assays (miR-27a, miR-21, miR23b, and miR-141)
showed a dynamic range of 6 logs, while at least 20 fM
synthetic miRNA in a miR-Q reaction were measured. All
of the calculated coefficients of determination (R2) ranged
between 0.9874 and 0.9996, which underlined the emi-
nent linearity between Ct values and miRNA input (Figure
3). Negative controls were established for all of the ten
studied assays by performing RT reactions with non-
spiked bacterial total RNA. All studied miR-Q negative
control assays gave neither a detectable, nor specific signal
over 40 cycles.
Assay specificity and cross reaction between let-7 family 
members
The discriminative power and specificity of the miR-Q
approach were analysed for three closely sequence-related
members of the let-7 family (let-7a, let-7b, and let-7c),
which differed only in one or two nucleotides (Table 1).
Each synthetic miRNA molecule was applied to each spe-
cific assay and the cross reaction of an assay was deter-
mined at different miRNA concentrations by offering
unspecific miRNA targets. All experiments were per-
formed along the entire dynamic range of assays (2 nM –
2 fM in a miR-Q reaction). Absolute quantification of
assay-unspecific targets was performed using a calibration
curve established with specific targets. The percentage of
cross reaction values was calculated between assay-spe-
cific and unspecific miRNA targets, while the concentra-
tion of assay-specific molecules represented the full value.
The miR-Q approach showed a high capability to discrim-
inate between miRNA molecules, which differ by less than
two nucleotides. Marginal cross reaction was only
observed at miRNA concentrations higher than 200 fM
synthetic miRNA in a miR-Q assay with minute values
ranging from 0% to 0.37%, indicating the high specificity
and selectivity of each let-7 assay (Table 2). For miRNA
concentrations below 200 fM, only the assay-specific
miRNA was detected. The highest cross reaction values
(0.37%) were observed using the let-7a assay and syn-
thetic let-7c at high concentrations. No cross reaction at
all was detected using the let-7a assay versus let-7b as a tar-
get.
Comparison of the miR-Q approach with a commercial 
qRT-PCR detection kit
Currently, few commercial miRNA qRT-PCR assays are
available. The mirVana™ qRT-PCR miRNA Detection Kit
for let-7b (Ambion) has been applied to validate the per-
formance of the miR-Q assay. The selected commercial
assay is well suited for this purpose, since it is also based
on an initial RT reaction, followed by SYBR Green quanti-
fication. Since our let-7b assay offered a characteristic
medium linearity (7 orders of magnitude), we decided to
compare the sensitivity and quantitative power of the
miR-Q approach with the competitor using let-7b. Both
assays were compared, performing reactions according to
the manufacturer's protocol, as well as to our new
method. For this purpose, 50 ng of bacterial total RNA
was spiked with synthetic let-7b to give final concentra-
tions between 10 nM and 10 fM in RT reaction. cDNAs
were quantified in subsequent qPCRs, which were simi-
larly carried out, according to both protocols comparing
the performace of both methods within the same qPCR
run. Regardless of the two different assay conditions, the
miR-Q approach provided a higher sensitivity and linear-
ity, characterised by slightly lower Ct values and a higher
dynamic range (Figure 4). While the competitor assay pro-
vided linearity over 6 orders of magnitude with a sensitiv-
ity limit at 20 fM synthetic let-7b under optimal
conditions, as little as 2 fM synthetic let-7b was detected
using the miR-Q assay (Figure 4). Both assays showed
excellent amplification efficiencies, ranging between 0.95
and 0.98 and R2 > 0.996.
Additionally, human total RNA samples from the cell
lines A549, HeLa, and HT-29 were employed to validate
the performance of the miR-Q assay in real human sam-
ples. For this purpose total RNA samples (50 ng/μl) were
either spiked with 100 pM synthetic let-7b (spike-in con-
trols) or remained non-spiked (samples). RT reactions
were performed with 50 ng, 25 ng, and 5 ng of all RNA
Table 2: Cross reaction of the miR-Q let-7 assays at different 
target concentrations. The percentage of cross reaction values 
was calculated between assay-specific and unspecific miRNA 
targets, while concentration of assay-specific molecules 
represented the full value.
let-7a miR-Q let-7b miR-Q let-7c miR-Q
2 nM let-7a 100 0.31 0.01
2 nM let-7b 0.00 100 0.23
2 nM let-7c 0.37 0.29 100
200 pM let-7a 100 0.31 0.01
200 pM let-7b 0.00 100 0.13
200 pM let-7c 0.24 0.24 100
20 pM let-7a 100 0.30 0.01
20 pM let-7b 0.00 100 0.10
20 pM let-7c 0.24 0.19 100
2 pM let-7a 100 0.00 0.00
2 pM let-7b 0.00 100 0.00
2 pM let-7c 0.00 0.16 100
200 fM let-7a 100 0.00 0.00
200 fM let-7b 0.00 100 0.00
200 fM let-7c 0.00 0.00 100
20 fM let-7a 100 0.00 0.00
20 fM let-7b 0.00 100 0.00
20 fM let-7c 0.00 0.00 100
2 fM let-7a 100 0.00 0.00
2 fM let-7b 0.00 100 0.00
2 fM let-7c 0.00 0.00 100BMC Molecular Biology 2008, 9:34 http://www.biomedcentral.com/1471-2199/9/34
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samples. The specificity was validated performing side-by-
side quantification of let-7b using the miR-Q assay as well
as the mirVana™ qRT-PCR miRNA Detection Kit. As
shown in Figure 5, let-7b was detected both in spike-in
controls and in non-spiked samples using both assays.
Both methods revealed consistent high natural let-7b
expression in HT-29 cells compared with the other ana-
lysed cell lines (Figure 5). It has to be taken into account
that the comparative quantification of let-7b by means of
the two methods was carried out in two independent
qPCR runs. Due to differences between separate qPCR
runs, comparative analysis of both methods was per-
formed by calculation of ratios between spike-in controls
and non-spiked samples. Both assays exhibited consistent
linearity between the spike-in controls and the non-
spiked samples demonstrated by the calculated ratio. For
example, the miR-Q ratios at different HT-29 RNA con-
centrations averaged 4.3 ± 0.3 (Figure 5A) and the side-by-
side quantification using the mirVana assay resulted in a
mean ratio of 3.0 ± 0.2 (Figure 5B).
Expression of miR-145 and miR-21 in porcine intestinal 
samples
In order to test for a demanding practical application,
aside from an experimental validation of the assays, the
miR-Q approach was used to study differential miRNA
expression in biological samples. Therefore, the miR-Q
approach was introduced to generate miRNA expression
profiles of different porcine intestinal tissues. Target quan-
tity was determined by absolute quantification [12], using
a calibration curve established by reverse transcription of
serially diluted amounts of the particular synthetic
miRNA in the presence of 50 ng bacterial total RNA. The
expression profiles of two selected miRNAs (miR-145 and
miR-21) were exemplified in 50 ng porcine total RNA iso-
lated from the jejunum or ileum of ten piglets by means
of the corresponding miR-Q assays (Figure 6). After meas-
uring 5S ribosomal RNA (rRNA) expression as a house-
keeping gene, miRNA data were normalised by calculating
the ratios of miRNA and 5S rRNA expression values. The
expression of 5S rRNA in porcine jejunum and ileum
showed low variation among the ten analysed subjects
and turned out to be a reliable housekeeping gene for the
normalisation of miRNA values (data not shown). The
inter-assay variation of 5S rRNA gene expression among
the ten analysed samples was determined as a coefficient
of variation (CV) in percent [21]. The calculated CV for
the ten ileal samples were 32% and 21% for the jejunal
samples, respectively.
Expression of miR-145 and miR-21 in analysed samples
was first evaluated by performing initial miRNA-Microar-
ray experiments (data not shown). Subsequent miR-Q
analysis demonstrated that both miR-145 and miR-21
were differentially expressed in the jejunal and ileal sam-
ples of all ten piglets (Figure 6). There was an obvious
individual variance in expression of both miRNAs among
the studied subjects. However, miR-145 expression levels
in the two different intestinal loci showed similar tenden-
cies. As shown in Figure 6A and 6B, animal f exhibited the
highest miR-145 expression among the ten samples, both
in jejunum and ileum. Interestingly, both intestinal loci of
this animal featured the same miR-145:5S rRNA value,
which was twice as high as the lowest expression ratios
among the group.
Differential miR-21 expression was also observed among
jejunal or ileal samples, respectively. However, there was
no distinct concordance of miR-21 expression in the two
intestinal loci compared with miR-145 expression. The
highest miR-21:5S rRNA expression ratios within the ileal
samples were about 2.5 times higher compared with the
lowest values, while the highest expression value among
the jejunal samples turned out to be 3.5 times higher (Fig-
ure 6C and 6D).
Expression values of miR-21 were enhanced in both the
ileum and jejunum of all analysed animals compared
with miR-145. In ileal samples, a 30-fold higher miR-21
expression value was measured compared with miR-145,
while the average values in jejunum were enhanced 40-
fold.
Detection and quantification of synthetic let-7b in the pres- ence of a complex background using the miR-Q assay and  mirVana™ qRT-PCR Detection Kit within the same qPCR  run according to the mirVana protocol Figure 4
Detection and quantification of synthetic let-7b in 
the presence of a complex background using the 
miR-Q assay and mirVana™ qRT-PCR Detection Kit 
within the same qPCR run according to the mirVana 
protocol. The purchasable let-7b assay showed a sensitivity 
limit of 20 fM synthetic let-7b (black columns), while the sen-
sitivity limit of the miR-Q assay turned out to be 2 fM syn-
thetic let-7b (white columns). Each column represents the 
mean (± SD) of three measurements.
let-7b concentration [fM]
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t
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Side-by-side quantification of let-7b in human total RNA samples isolated from the cell lines: A549, HeLa, and HT-29 in two  independent qPCR runs Figure 5
Side-by-side quantification of let-7b in human total RNA samples isolated from the cell lines: A549, HeLa, and 
HT-29 in two independent qPCR runs. Experiments were performed using the miR-Q approach as well as the mirVana™ 
qRT-PCR Detection Kit. For this purpose, total RNA samples (50 ng/μl) were either spiked with 100 pM synthetic let-7b 
(A549 si, HeLa si, and HT-29 si) or remained non-spiked (A549, HeLa, and HT-29). RT reactions were performed with 50 ng, 
25 ng, and 5 ng of all RNA samples, followed by qPCR detection of let-7b in different runs. Columns represent the mean (± 
SD) of three measurements. A) let-7b quantification by means of the miR-Q approach using both the spike-in controls and the 
non-spiked samples. B) Quantification of let-7b by means of mirVana™ qRT-PCR using both the spike-in controls and the non-
spiked samples.
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Discussion
The expression of various protein coding genes, their role
in development or disease, and their regulation become
more and more deciphered. Recently, the small non-cod-
ing miRNAs have been highlighted as major modulators
of eukaryotic gene expression. It is suggested that up to
30% of human genes may be under the control of miR-
NAs [22]. MiRNAs are involved in essential developmen-
tal processes such as timing, embryogenesis,
organogenesis, growth control, and programmed cell
death; but they also play a role in human disease, in par-
ticular cancer [23]. An increasing number of studies
describe aberrant miRNA expression in cancerous tissue.
For example, miR-21 was reported as being highly overex-
pressed in human glioblastoma tumour tissue [24] and in
breast tumours, pointing to its function as an oncogene
[25]. Other miRNAs such as miR-143 or miR-145 are
downregulated in colon carcinomas [26] or in human
breast cancer [27]. In many cases, detection of miRNAs
and comparative miRNA expression analysis are per-
formed using methods based on probe hybridisation,
lacking any amplification step (Northern blot and Micro-
array). Despite these methods being well established, they
are rather limited regarding sensitivity and accurate quan-
tification. Otherwise, due to its high level of sensitivity,
accuracy, and practical ease, qRT-PCR is accepted as being
a powerful technique in comparative expression analysis
in life sciences and medicine [28]. In consideration of the
aforementioned facts, quantification of miRNA expres-
sion by real-time PCR (e.g. as a diagnostic tool in cancer
research) is the method of choice. However, few qRT-PCR
approaches are adapted to small-sized miRNAs [18,24]
and are currently made available by companies. Our miR-
Q approach represents a new, alternative method, which
exhibits advanced discriminative power and sensitivity. It
is based on primer extension, followed by amplification
and quantification of the corresponding cDNA, based on
the SYBR Green intercalating chemistry. To establish a
novel PCR approach for RNA molecules (< 30 nt) such as
miRNAs, three different oligonucleotides were simultane-
ously employed, one miRNA-specific molecule (short-
miR-x-rev) for the detection of the corresponding cDNA
and two universal primers for the exponential amplifica-
tion of the product.
We established the described 10 miR-Q assays by ran-
domly choosing miRNAs of interest. Since all of the vali-
dated assays proved to be highly sensitive and specific and
Expression of miR-145 and miR-21 in porcine intestinal samples Figure 6
Expression of miR-145 and miR-21 in porcine intestinal samples. MiRNA expression values were normalised with 
relating 5S rRNA expression data and are given as ratios of expression. Each column represents the mean (± SD) of three 
measurements. A) Expression of miR-145 in ileal samples from ten 31-day-old piglets. B) Expression of miR-145 in jejunal sam-
ples from ten 31-day-old piglets. C) Expression of miR-21 in ileal samples from ten 31-day-old piglets. D) Expression of miR-21 
in jejunal samples from ten 31-day-old piglets.
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because of the nature of the overhang sequences, we con-
clude that these sequence parts can be utilised for ubiqui-
tous detection of small RNA molecule. The linearity and
sensitivity of the proposed approach apparently correlates
with the length of the detected miRNA molecule. Accord-
ing to miRBase sequence data [20], miR-145 has an
extended length of 24 nt, displaying the longest molecule
among the miRNAs in this study. Consequently, the most
sensitive assay among the validated ten assays (linearity
over 8 orders of magnitude) turned out to be the miR-145
assay, featuring an advanced sensitivity limit. Moreover,
most of the analysed miRNA molecules with a length of
22 nt exhibited enhanced assay linearity, compared with
shorter molecules. Currently, 475 human miRNAs are
published in miRBase (Release 9.2). Based on these data,
67% of known human miRNAs are at least 22 nt in length.
Accordingly, it can be suggested that the general detection
limit of the miR-Q approach would be about 1 fM
miRNA. This value may even be underestimated, since
27% of known human miRNAs are longer than 22 nt. Dif-
ferent tissues or cell types may contain diverse amounts of
RNA. But according to our calculations, a general detec-
tion limit of 2 fM correlates with less than 5 measured
copies of miRNA molecules per cell. Hence, the proposed
approach offers a cost-effective alternative, exhibiting
improved sensitivity and specificity compared with other
existing methods without using fluorochromic hybridisa-
tion probes or LNA-modified oligonucleotides [18,19].
Recently, qRT-PCR protocols for profiling of mature miR-
NAs have been introduced where the entire miRNA popu-
lation contained in samples is reverse transcribed at the
same time (Invitrogen or Qiagen). The application of spe-
cific RT primers, however, provides an increased specifi-
city of the assays and reduces cross reaction between
closely related miRNA molecules. The gain of higher sen-
sitivity over existing assays is also underlined by compari-
son of our let-7b assay with a purchasable kit. While the
mirVana™ qRT-PCR miRNA Detection Kit for let-7b pro-
vided lower detection limit, the miR-Q let-7b assay turned
out to possess an enhanced dynamic range. Furthermore,
the miR-Q assay turned out to be highly discriminative,
exhibiting almost no cross reaction between related
miRNA molecules, which differed by at least one base. As
shown in the let-7a assay versus let-7b as a target, the opti-
misation of the approach's discriminative power can be
achieved by positioning the terminal 3' nucleotide of
short-miR-x-rev at one of the mismatched bases. Since in
real human samples the RNA species are much richer, we
performed side-by-side quantification of let-7b in differ-
ent human cell lines using miR-Q and mirVana™ qRT-PCR
and comparing the outcomes of the different assays. The
miR-Q results such as the ratios between the spike-in con-
trols and the non-spiked samples were verified using the
commercial kit, pointing to the specificity of the miR-Q
assay to detect mature miRNA molecules.
To minimise possible sample-to-sample variation due to
imbalanced initial total RNA input, we chose 5S rRNA to
normalise miRNA expression. Based on the small size of
5S rRNA (representing the small RNA fraction in total
RNA samples) and its high conservation level among var-
ious species, it appears to be an appropriate gene for the
normalisation of miRNAs. Vandesompele et al. [21] stud-
ied the normalisation of qRT-PCR data by geometric
means. Depending on the selected genes, tissues, and
samples, they reported average CV values ranging from
15% to 50%. Despite the fact that we only used the 5S
rRNA expression values and not a geometric mean, our
calculated CV values correlate well with their data for
pooled tissues. Intestinal RNA samples used in this study
also represent a complex starting material, since the total
RNA was isolated from whole tissues.
miR-21 was reported as being overexpressed in various
human cancerous tissues, including colon carcinoma
[29,30] and represents an antiapoptotic factor [30]. While
common miRNA dysregulation in cancer seems to result
in a gain of expression [29], some miRNAs such as miR-
145 are downregulated in colorectal carcinomas [26,30].
Dysregulation of these miRNAs in human colorectal can-
cer points to their potential role in cell proliferation and
differentiation in intestinal tissues. Variation in porcine
miRNA expression among the ten examined piglets may
therefore reflect the individual differences in the intestinal
development of the animals. The measured miR-145 and
miR-21 expression values in porcine intestinal samples
should basically rely on detection of mature miRNA mol-
ecules. Within this context, Northern blot analysis and
qRT-PCR studies have already shown that the cellular
steady-state level of miRNA precursors is negligible, com-
pared with the mature miRNA [17,18].
Conclusion
Despite the existence of commercial miRNA qRT-PCR
approaches, there is an increasing need for fast, reliable,
and cost-effective assays, which are adaptable for any
research group interested in miRNA detection. Our miR-Q
approach provides a linearity of up to 8 orders of magni-
tude detecting as low as 0.2 fM miRNA molecules.
It offers an alternative method for scientists interested in
detecting and quantifying miRNA expression in total RNA
samples from different species and tissues.
Methods
Oligonucleotides and synthetic miRNA molecules
Ten known miRNA molecules were chosen, inter alia,
according to preliminary miRNA-Microarray screening
experiments using porcine intestinal samples. These
miRNA sequences were chosen from the miRBase
Sequence database Release 9.2 [20] and oligonucleotidesBMC Molecular Biology 2008, 9:34 http://www.biomedcentral.com/1471-2199/9/34
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were designed for every assay (Table 1). Synthetic miRNA
molecules were used for the validation of assays. All DNA-
and RNA-oligonucleotides were synthesised by Metabion
AG (Martinsried, Germany).
Total RNA isolation from samples
Human total RNA from the cervical carcinoma cell line
HeLa (ATCC No.: CCL-2), the colon carcinoma cells HT-
29 (ATCC No.: HTB-38), and the lung carcinoma cell line
A549 (ATCC No.: CCL-185) as well as porcine total RNA
from intestinal tissues were prepared using the mirVana
miRNA Isolation Kit (Ambion, Darmstadt, Germany),
according to the manufacturer's protocol. The porcine
intestinal samples included the jejunum and ileum of ten
31-day-old piglets (EUROC × Pietrain).
In order to validate the new assays, bacterial total RNA
was employed as an unspecific complex RNA background
in reverse transcription (RT) reactions. RNA was isolated
from Escherichia coli DH5á using the Invisorb Spin Cell
RNA Mini Kit (Invitek, Berlin, Germany), according to the
manufacturer's protocol.
The RNA quality and quantity of all samples were proven
using the Agilent 2100 Bioanalyzer and the RNA Nano
Chips (Agilent, Waldbronn, Germany).
Reverse transcription
The validation of every assay was performed by RT of cer-
tain amounts of the corresponding synthetic miRNA with
50 ng bacterial total RNA present, representing a complex
RNA background. Furthermore, the human total RNA as
well as the porcine intestinal total RNA were used for
reverse transcription.
250 fmol of the miRNA-specific DNA-oligonucleotide
(RT6-miR-x) with 5' overhang and the RevertAid™ M-
MuLV Reverse Transcriptase (Fermentas GmbH, St. Leon-
Roth, Germany) were employed to transcribe miRNA into
cDNA. A mixture of 50 ng human or porcine total RNA or
bacterial total RNA spiked with synthetic miRNA and RT6-
miR-x was first prepared in a 4 μl volume. The mixture was
incubated at 70°C for 5 min and chilled on ice. Then, the
volume was brought up to 10 μl by adding the RT-Buffer,
1 mM dNTPs, 100 U Reverse Transcriptase and water. The
reaction was incubated at 37°C for 5 min followed by
42°C for 60 min. The enzyme was inactivated by heating
at 70°C for 10 min. The standard was prepared using 50
ng of bacterial total RNA spiked with different amounts of
synthetic miRNA (10 nM – 1 fM in RT reaction) and was
applied for validation and for preparation of qPCR cali-
bration curves. 50 ng of non-spiked bacterial total RNA
was used as negative control.
Quantitative PCR
The optimal annealing temperature (Tanopt) for every miR-
Q assay was first proven by performing a conventional
PCR with an annealing temperature gradient ranging from
53 to 65°C. The reaction was performed with 4 nM short-
miR-x-rev, 100 nM MP-fw, and 100 nM MP-rev using the
Immolase DNA Polymerase (Bioline, Luckenwalde, Ger-
many). The reaction was carried out according to the
qPCR conditions (see below) in 25 μl final volume using
2 μl of cDNA, which was obtained from RT reaction with
10 pM of the particular synthetic miRNA. The product size
ranged from 82 to 85 bp, depending on the miRNA being
detected. After the Tanopt was determined, the cDNA was
quantified using the Rotor-Gene 3000 real-time Detection
System (Corbett Life Science, Sydney, Australia) as well as
the StepOnePlus™ Real-Time PCR System (Applied Bio-
systems, Darmstadt, Germany). For this purpose, tripli-
cate measurements of 2 μl cDNA were made in 10 μl final
reaction volume. SYBR Green qPCR was performed using
the SensiMix DNA Kit (Quantace Ltd., Berlin, Germany),
4 nM short-miR-x-rev, 100 nM MP-fw, and 100 nM MP-rev.
The amplification was carried out via the first step at 95°C
for 10 min, followed by 40 cycles with 15 s at 95°C, 10 s
at the particular annealing temperature (Table 1), and 20
s at 72°C. The fluorescence signal was acquired at 72°C
and the Ct values were converted into fM miRNA, using a
miRNA-specific calibration curve. MiRNA amounts were
determined by triplicate measurements for each sample,
compared with a calibration curve established by reverse
transcription of serially diluted amounts of the particular
synthetic miRNA in the presence of 50 ng bacterial total
RNA. The RT reaction of non-spiked bacterial total RNA
samples and no template controls were used as negative
controls.
5S ribosomal RNA normalisation
Sample-to-sample variation of miRNA expression in por-
cine intestinal samples was corrected by normalisation
with 5S rRNA chosen as a housekeeping gene. Firstly, 50
ng of porcine total RNA was reverse-transcribed using the
RevertAid™ M-MuLV Reverse Transcriptase (Fermentas
GmbH), according to the manufacturer's protocol using
random Hexamers. 5S rRNA molecules were quantitated
by triplicate measurements of 2 μl cDNA in 10 μl final
reaction volume. SYBR Green qPCR was performed using
the SensiMix DNA Kit (Quantace Ltd.) and 0.2 μM of each
primer 5S rRNA-fw and 5S rRNA-rev (table 1). Amplifica-
tion was carried out via the first step at 95°C for 10 min,
followed by 40 cycles with 15 s at 95°C, 10 s at 60°C and
20 s at 72°C, providing an amplicon of 114 bp. The fluo-
rescence signal was acquired at 72°C and Ct values were
converted into fg 5S rRNA per qPCR reaction using a cali-
bration curve, which was established by serial dilutions of
the corresponding PCR product. Normalisation was per-BMC Molecular Biology 2008, 9:34 http://www.biomedcentral.com/1471-2199/9/34
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formed by calculating the miRNA:5S rRNA expression
ratios.
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